US drug policy does not align with experts' rankings of drug harms: a multi-criteria decision analysis.

Saved in:
Bibliographic Details
Title: US drug policy does not align with experts' rankings of drug harms: a multi-criteria decision analysis.
Authors: Broman M; College of Social Work, The Ohio State University, Columbus, OH, USA. broman.6@osu.edu.; Center for Psychedelic Drug Research and Education, The Ohio State University, Columbus, OH, USA. broman.6@osu.edu., Davis AK; College of Social Work, The Ohio State University, Columbus, OH, USA.; Center for Psychedelic Drug Research and Education, The Ohio State University, Columbus, OH, USA., Armstrong S; Center for Psychedelic Drug Research and Education, The Ohio State University, Columbus, OH, USA., Levin A; Center for Psychedelic Drug Research and Education, The Ohio State University, Columbus, OH, USA., Ahmed K; College of Social Work, The Ohio State University, Columbus, OH, USA., Angarita GA; Department of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA.; Clinical Neuroscience Research Unit, Connecticut Mental Health Center, New Haven, CT, USA., Arterberry BJ; Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA., Bergeria C; Department of Psychiatry and Behavioral Sciences, School of Medicine, John Hopkins University, Baltimore, MD, USA., Earleywine M; Department of Psychology, University at Albany, Albany, NY, USA., Gex KS; College of Medicine, Medical University of South Carolina, Charleston, SC, USA., Gregoire T; College of Social Work, The Ohio State University, Columbus, OH, USA., Lister JJ; Northeast & Caribbean Rural Opioid Technical Assistance Center, School of Social Work, The State University of New Jersey, Rutgers, New Brunswick, NJ, USA., Mathai DS; Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA.; Sattva Medicine, Miami, FL, USA., Mehtani NJ; Division of General Internal Medicine, University of California, San Francisco, San Francisco, CA, USA., Menke N; University of Michigan Medical School, Ann Arbor, MI, USA., Nichols CD; School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Shaub H; Center for Psychedelic Drug Research and Education, The Ohio State University, Columbus, OH, USA., Tackett AP; Division of Medical Oncology, College of Medicine, The Ohio State University, Columbus, OH, USA., Weiss B; Center for Psychedelic & Consciousness Research, Johns Hopkins University, Baltimore, MD, USA., Yalin N; Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychology, Psychiatry, and Neurosciences, King's College London, London, UK., Phillips LD; London School of Economics and Political Science, London, UK.
Source: Harm reduction journal [Harm Reduct J] 2025 Dec 31; Vol. 23 (1), pp. 17. Date of Electronic Publication: 2025 Dec 31.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101153624 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7517 (Electronic) Linking ISSN: 14777517 NLM ISO Abbreviation: Harm Reduct J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1477-7517
DOI:10.1186/s12954-025-01390-x